Latest News

Instem Expands In Silico Toxicology Service To Meet Growing Demand

Newly Added Services to Support Latest Regulatory Guidance and Growing Demand for Alternative Testing Methods

PHILADELPHIA, PA – (BUSINESS WIRE) – November 22, 2021 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has further enhanced its  Predict™ In Silico Toxicology service portfolio by adding four new services.


Instem Acquires PDS Life Sciences to Help Clients Bring Life Enhancing Products to Market Faster and More Efficiently

September 1, 2021 - Acquisition of PDS Life Sciences Consolidates Non-Clinical Market; Further Extends Instem’s Leadership in Study Management and Regulatory SEND Submission Support


Instem to Release Next Edition of its Leading Computational Toxicology Software Suite

July 29, 2021 - Powerful New In Silico Models and First-to-Market Software Capabilities to Deliver Further Efficiencies and Increased Regulatory Compliance


Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

March 22, 2021 - Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission


Instem Announces Acquisition of The Edge; Extends Reach within Discovery R&D

March 1, 2021 - Instem’s Acquisition of Discovery Technology Solutions Provider, The Edge, Represents Another Advancement of its Mission in the Life Sciences


View all news

 

Events

38th Annual Meeting of the Japanese Society of Toxicologic Pathology (STP)

January 27 - 28, 2022

Kobe International Conference Center, Hyogo, Japan

Visit Conference Site


SOT 61st Annual Meeting

March 27 - 31, 2022

San Diego Convention Center, San Diego, Booths #1625 & #1729

Presentation
Assessment of whether acute toxicity in silico models are fit-for-purpose for classification and labelling
Wednesday, March 30

Visit Conference Site

 

View all events